المؤلفون: Jose Lopez-Sendon, Maurizio Averna, Daniel Gaudet, Alexia Letierce, Maciej Banach, Patrick Henry, Megan Loy, Isabela Batsu, Gregory Bigot, Garen Manvelian, Rita Samuel

المصدر: European Journal of Preventive Cardiology. 28:1864-1872

مصطلحات موضوعية: Adult, Male, myalgia, Canada, medicine.medical_specialty, Statin, Epidemiology, medicine.drug_class, 030204 cardiovascular system & hematology, Antibodies, Monoclonal, Humanized, Real life setting, 03 medical and health sciences, 0302 clinical medicine, Dose adjustment, Internal medicine, medicine, Humans, In patient, Prospective Studies, 030212 general & internal medicine, Adverse effect, Aged, Alirocumab, business.industry, Incidence (epidemiology), Middle Aged, Treatment Outcome, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87073ffd1dc9968fd83c5218d4ca9b7Test
https://doi.org/10.1093/eurjpc/zwaa097Test

المؤلفون: Raeesa Thasneem, Elsa Poulose, Elizabeth Rita Samuel, Ananthu T Mani, Austin Origin

المصدر: 2021 IEEE Region 10 Symposium (TENSYMP).

مصطلحات موضوعية: business.industry, media_common.quotation_subject, Environmental resource management, Grid, Solar energy, Maintenance engineering, Energy storage, Renewable energy, Environmental science, business, Lead–acid battery, Function (engineering), Solar power, media_common

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0a4bac22ebcb44465523954e30776042Test
https://doi.org/10.1109/tensymp52854.2021.9551010Test

المؤلفون: Christopher P. Cannon, Robert S. Rosenson, Rita Samuel, Alexia Letierce, Yann Poulouin, G. Kees Hovingh, Henry N. Ginsberg

المساهمون: Experimental Vascular Medicine, Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes

المصدر: Journal of lipid research, 63(1):100148. American Society for Biochemistry and Molecular Biology Inc.
Journal of Lipid Research, Vol 63, Iss 1, Pp 100148-(2022)

مصطلحات موضوعية: Drug therapy/hypolipidemic drugs, Correlation coefficient, Calculated LDL-C, business.industry, Cholesterol, LDL, QD415-436, Cell Biology, NIH equation 2, Beta-quantification, Biochemistry, LDL, Martin-Hopkins, PCSK9, Cholesterol, Friedewald, Endocrinology, Treatment decision making, PCSK9 Inhibitors, Nuclear medicine, business, Treatment Arm, Alirocumab, Mathematics

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789d5ac0144a4fe60289eb9f98a87287Test
https://doi.org/10.1016/j.jlr.2021.100148Test

المؤلفون: Lawrence A. Leiter, Kausik K. Ray, Antonio J. Vallejo-Vaz, Rita Samuel, Jonas Mandel, Alexia Letierce, Maja Bujas-Bobanovic, Dirk Müller-Wieland, Stefano Del Prato, Marja-Riitta Taskinen

المساهمون: Universidad de Sevilla. Departamento de Medicina, Regeneron Pharmaceuticals, Inc., Sanofi

المصدر: European Journal of Preventive Cardiology

مصطلحات موضوعية: Male, Cardiac & Cardiovascular Systems, Epidemiology, 030204 cardiovascular system & hematology, NON-HDL CHOLESTEROL, Full Research Paper, DISEASE, HYPERCHOLESTEROLEMIA, chemistry.chemical_compound, 0302 clinical medicine, non-high-density lipoprotein cholesterol, 030212 general & internal medicine, Lipoprotein cholesterol, proprotein convertase subtilisin, 2. Zero hunger, Alirocumab, goal attainment, low-density lipoprotein cholesterol, proprotein convertase subtilisin/kexin type 9, triglycerides, Middle Aged, REMNANT CHOLESTEROL, Non-high-density lipoprotein cholesterol, Treatment Outcome, Cardiovascular Diseases, SAFETY, lipids (amino acids, peptides, and proteins), Female, Seasons, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, kexin type 9, Goals, medicine.drug, medicine.medical_specialty, EZETIMIBE, Proprotein convertase subtilisin/kexin type 9, Antibodies, Monoclonal, Humanized, RESIDUAL RISK, 03 medical and health sciences, Ezetimibe, Internal medicine, medicine, Humans, Low-density lipoprotein cholesterol, Triglycerides, Science & Technology, Triglyceride, Dose-Response Relationship, Drug, business.industry, CARDIOVASCULAR-RISK PATIENTS, Non high density lipoprotein cholesterol, Cholesterol, LDL, EFFICACY, Goal attainment, Residual risk, Endocrinology, chemistry, INHIBITOR ALIROCUMAB, Cardiovascular System & Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers, Lipoprotein

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec8c6fd395b5c478da5449379641bf48Test
https://pubmed.ncbi.nlm.nih.gov/32188296Test

المؤلفون: Catherine Domenger, Stefano Del Prato, Helen M. Colhoun, Bertrand Cariou, Marc Israel, Kausik K. Ray, Rita Samuel, Alexia Letierce, Francisco J. Tinahones, Dirk Müller-Wieland, Lawrence A. Leiter

المصدر: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-11 (2020)
Cardiovascular Diabetology
Cardiovascular diabetology 19, 14 (2020). doi:10.1186/s12933-020-0991-1
Colhoun, H M, Leiter, L A, Müller-Wieland, D, Cariou, B, Ray, K K, Tinahones, F J, Domenger, C, Letierce, A, Israel, M, Samuel, R & Del Prato, S 2020, ' Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol ', Cardiovascular diabetology, vol. 19, no. 1, pp. 14 . https://doi.org/10.1186/s12933-020-0991-1Test

مصطلحات موضوعية: Non-HDL-C, Male, lcsh:Diseases of the circulatory (Cardiovascular) system, Cardiac & Cardiovascular Systems, Time Factors, Apolipoprotein B, Endocrinology, Diabetes and Metabolism, RATIONALE, Type 2 diabetes, Gastroenterology, PCSK9, Diabetes mellitus, DESIGN, Monoclonal, 1102 Cardiorespiratory Medicine and Haematology, Humanized, Original Investigation, RISK, Fenofibrate, biology, Anticholesteremic Agents, PCSK9 Inhibitors, Usual care, ASSOCIATION, Middle Aged, Cholesterol, Treatment Outcome, SAFETY, lipids (amino acids, peptides, and proteins), Female, ODYSSEY, Proprotein Convertase 9, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, INTERVENTION, Type 2, medicine.drug, medicine.medical_specialty, Statin, HDL, medicine.drug_class, Antibodies, Monoclonal, Humanized, Antibodies, POOLED ANALYSIS, Endocrinology & Metabolism, Ezetimibe, Internal medicine, MANAGEMENT, medicine, Humans, Alirocumab, DM-DYSLIPIDEMIA, HDL-C, Triglycerides, Aged, Biomarkers, Cholesterol, HDL, Diabetes Mellitus, Type 2, Dyslipidemias, Protease Inhibitors, ddc:610, ESC/EAS GUIDELINES, Science & Technology, business.industry, nutritional and metabolic diseases, medicine.disease, REDUCTION, Cardiovascular System & Hematology, lcsh:RC666-701, Cardiovascular System & Cardiology, biology.protein, business, Dyslipidemia

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60871df43dd01a7c43ca9bd3ed8e2362Test

المؤلفون: Elizabeth Rita Samuel, A. Unnikrishnan, P. K. Prathibha

المصدر: Springer Transactions in Civil and Environmental Engineering ISBN: 9789811510625

مصطلحات موضوعية: Electric motor, business.product_category, business.industry, Fossil fuel, Combustion, Automotive engineering, State of charge, Electrification, Electric vehicle, Environmental science, MATLAB, business, computer, Driving cycle, computer.programming_language

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4d8a98a91a1948895df68dd64676a89dTest
https://doi.org/10.1007/978-981-15-1063-2_42Test

المؤلفون: Bertrand Cariou, Alexia Letierce, Dirk Müller-Wieland, Lawrence A. Leiter, Marie T. Baccara-Dinet, Rita Samuel

المصدر: Diabetic medicine 35(1), 121-130 (2017). doi:10.1111/dme.13450
Diabetic Medicine

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Gastroenterology, 0302 clinical medicine, Endocrinology, Medicine, 030212 general & internal medicine, Prediabetes, Research Articles, Randomized Controlled Trials as Topic, education.field_of_study, Anticholesteremic Agents, Antibodies, Monoclonal, Research: Treatment, Middle Aged, Treatment Outcome, Female, medicine.drug, Adult, medicine.medical_specialty, Statin, medicine.drug_class, Hypercholesterolemia, Population, Antibodies, Monoclonal, Humanized, Placebo, Prediabetic State, 03 medical and health sciences, Double-Blind Method, Ezetimibe, Internal medicine, Diabetes mellitus, Internal Medicine, Humans, education, Triglycerides, Aged, Alirocumab, Glycated Hemoglobin, business.industry, PCSK9, Cholesterol, LDL, medicine.disease, Treatment, Clinical Trials, Phase III as Topic, Case-Control Studies, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96a66b0612eb40ed576e9c9e9ebba4eTest
https://doi.org/10.1111/dme.13450Test

المؤلفون: Elizabeth Rita Samuel, S Reshma, A. Unnikrishnan

المصدر: 2019 2nd International Conference on Intelligent Computing, Instrumentation and Control Technologies (ICICICT).

مصطلحات موضوعية: Electric motor, business.product_category, 020208 electrical & electronic engineering, Gas emissions, 02 engineering and technology, Combustion, 01 natural sciences, Automotive engineering, 010305 fluids & plasmas, Internal combustion engine, Electrically powered spacecraft propulsion, 0103 physical sciences, Electric vehicle, 0202 electrical engineering, electronic engineering, information engineering, Torque, Environmental science, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f7179b7f0825a3c1ef2146865d20af04Test
https://doi.org/10.1109/icicict46008.2019.8993211Test

المؤلفون: Aakash V Nambiar, Edwin Lawrence P, Jees John, Elizabeth Rita Samuel, Nikhil V Philip, K P Thomas

المصدر: 2019 2nd International Conference on Intelligent Computing, Instrumentation and Control Technologies (ICICICT).

مصطلحات موضوعية: Battery (electricity), Engineering, business.product_category, Work (electrical), business.industry, Controller (computing), Electric vehicle, Transmission system, Solar powered, business, Hybrid vehicle, Automotive engineering

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a94e7d2dc9b957a3f70893d51b76578bTest
https://doi.org/10.1109/icicict46008.2019.8993320Test

المؤلفون: Jonas Mandel, Lawrence A. Leiter, Rita Samuel, Dirk Müller-Wieland, Maja Bujas-Bobanovic, Stefano Del Prato, Alexia Letierce, Kausik K. Ray, Bertrand Cariou, Francisco J. Tinahones, Catherine Domenger, Helen M. Colhoun

المصدر: Ray, K K, Del Prato, S, Müller-Wieland, D, Cariou, B, Colhoun, H M, Tinahones, F J, Domenger, C, Letierce, A, Mandel, J, Samuel, R, Bujas-Bobanovic, M & Leiter, L A 2019, ' Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease : analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies ', Cardiovascular diabetology, vol. 18, no. 1, pp. 149 . https://doi.org/10.1186/s12933-019-0951-9Test
Cardiovascular Diabetology
Cardiovascular diabetology 18, 149 (2019). doi:10.1186/s12933-019-0951-9
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Cardiac & Cardiovascular Systems, Endocrinology, Diabetes and Metabolism, Coronary Disease, Type 2 diabetes, Clinical Trials, Phase IV as Topic, chemistry.chemical_compound, Risk Factors, Multicenter Studies as Topic, 1102 Cardiorespiratory Medicine and Haematology, Randomized Controlled Trials as Topic, Original Investigation, RISK, Anticholesteremic Agents, PCSK9 Inhibitors, Treatment Outcome, SAFETY, Drug Therapy, Combination, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, medicine.medical_specialty, Statin, Serine Proteinase Inhibitors, medicine.drug_class, Placebo, Antibodies, Monoclonal, Humanized, Endocrinology & Metabolism, Internal medicine, Diabetes mellitus, Type 2 diabetes mellitus, medicine, Humans, Low-density lipoprotein cholesterol, ddc:610, Alirocumab, Dyslipidemias, Science & Technology, Cholesterol, business.industry, PCSK9, Cholesterol, HDL, nutritional and metabolic diseases, Cholesterol, LDL, medicine.disease, Atherosclerosis, EFFICACY, chemistry, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Cardiovascular System & Hematology, Dyslipidemia, lcsh:RC666-701, Atherosclerotic cardiovascular disease, Cardiovascular System & Cardiology, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d3a05dee250a4541416b551ab40c13Test
http://hdl.handle.net/11568/1029810Test